AstraZeneca has agreed to sell part of its antibiotics business to Pfizer for up to $1.575 billion plus royalties, giving Pfizer the right to sell three approved drugs and two now in clinical trials in most markets outside the U.S.

Topics:  u.s    pfizer   astrazeneca   part   sell   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News